Tag: enasidenib

650×450-Cleveland-Clinic-Cancer
August 1, 2017/Cancer/News & Insight

Enasidenib Effective Treatment for Refractory Acute Myeloid Leukemia

Precision therapy for refractory disease now FDA approved

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad